Infectious complications of ANCA-associated vasculitis: Description and associated outcome

Jeanne Morin1, Pierre-André Jarrot2, Justine Solignac3

  • 1Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France.

Abstract

Insights

Infections are common in ANCA-associated vasculitis (AAV) and increase mortality risk. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis patients with anti-PR3 positivity face higher infection risks, while methotrexate shows a protective effect.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Rheumatology

Background:

  • Systemic complications, particularly infections, are significant causes of morbidity and mortality in ANCA-associated vasculitis (AAV).
  • Both the disease itself and its treatments contribute to these complications.

Purpose of the Study:

  • To evaluate the prevalence and prognosis of infectious complications in AAV.
  • To identify risk factors associated with infections in AAV patients.
  • To describe the long-term outcomes of infectious complications in AAV.

Main Methods:

  • Retrospective monocentric study including 264 patients with AAV.
  • Infection defined as requiring hospitalization or anti-infectious therapy.
  • Follow-up conducted until January 1st, 2025.

Main Results:

  • Infection incidence was 43.9%, with respiratory infections (49.1%) and bacterial infections (75.3%) being most common.
  • Risk factors included age >65, hypertension, diabetes, high Five-Factor Score, high BVAS, anti-PR3 positivity, acute kidney injury, cyclophosphamide, and intravenous corticosteroids.
  • Anti-PR3 positivity was an independent risk factor (aOR=2.0), while methotrexate was protective (aOR=0.08). Infections were linked to relapses (aOR=2.8) and cardiovascular events (aOR=3.0).
  • Mortality was significantly associated with infection (HR=2.14).

Conclusions:

  • Infections are frequent in AAV and independently impact mortality.
  • Anti-PR3 positivity is associated with increased infection risk.
  • Methotrexate demonstrates a protective effect against infections in AAV.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...